Thank you, Bizops for the questions.
I’ll answer the questions I can at the bottom of this post, and we’ve saved all of them to address in due time.
I’m trying to dialogue what I can because I understand how frustrating getting no news for extended amounts of time feels. It doesn’t help when the share price returns to its old baseline either. But personally, that doesn’t worry me a bit, I wasn’t going to sell at .99, so what’s .14 to me when nothing we have planned has been announced?
As you all know, the chill caught us by surprise and has hindered our announcements, but not our business plan. Criticism for us not anticipating this is fine. But I would say when a bureaucracy changes policy overnight it’s not easy to catch. For example, I’ve personally been unable to find anything online to trace this policy change. That’s where incumbents have an advantage as they have relationships in place to notify them of changes. Chas has persistently called up the chain(s) and appealed as much as possible. Worse case is that the OTC will not change our status until a quarterly with revenue is filed, but we are still appealing and will be notifying them as events develop to encourage sooner revision.
So why aren’t we releasing the 8K’s anyways? There is a case to be made on both sides. On the pro side good news now won’t be any less real when the chill is lifted. But the threat is that MM naked shorting and manipulation will continue unchecked on each burst of momentum. This is hard to prove, it doesn’t show up on reports, but those with experience in this market know naked shorting is a real problem. Over 40,000 shares traded Wednesday under 16 cents. I have a hard time imagining any one of our small but loyal base of shareholders sold those.
So we will keep most of our ammunition until is can be of more value.
As to what we can expect; this company is much bigger than Magnatech alone. While that’s are main technology and holds the biggest potential, we have other revenue streams in the works that we’ve discussed before. The Autogenous Impact Mill (AIM) and semi-conductor applications are just two that have already been mentioned.
_______________
Below our answers to Bizops questions. Answers are in bold.
Do they need funding before they go into production?
No. An 8-K will provide more information when funding is complete. With funding we can scale faster so it is a top priority.
Do they have a funding source currently they are working with or do they need to find a funding source?
What kind of funding are they looking for? Equity?
We have equity funding in process already at this time.
We were told they had a distributor agreement in place for diamonds – Is that accurate?
If they have and/or are entering into distribution agreements does that mean they plan to do full scale production themselves?
Do they plan to have one line of products or multiple lines? Do they plan to have multiple products within a line?
Will the initial focus be on industrial diamonds, jewelry grade diamonds, a combination or something else?
We never stated a distribution agreement was in place, only that it was in the works. When an official distribution agreement is in place we will notify the public.
Production is the heart of our business. This goes beyond Magnatech, and ancillary revenue streams are under development for both industrial and jewelry diamonds.
Are they confident the measurement feedback system of the MagnaTech process is complete (verified/tested) and ready for production?
R&D is still in its final stages. We aim for a Q3-2019 launch. Our current R&D site is currently being relocated to a facility that is more suitable and will complete this process.
Will the next 10k layout the business plan for investors to review? Will it have timing?
We will outline the bigger picture and plan going forward once our chill is removed and definite agreements have been established.
Will the licensing agreements they are working on consists of production that is the same as CTDT production or for different applications? Can you share what some of those applications might be?
We cannot share the details, but the potential licensing deal involved Alvin Snaper’s technology that is separate from Magnatech.
